There were 449 press releases posted in the last 24 hours and 156,006 in the last 365 days.

Align Technology and Straumann Group Terminate Discussions Concerning a Possible Development and Distribution Agreement

Straumann To Pay Align an Additional $16 Million to Complete Patent Settlement

SAN JOSE, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) and Straumann Group today announced that they have terminated discussions regarding a possible development and distribution agreement that was disclosed as part of the patent settlement agreement announced by the two companies in March. As a result, Straumann will pay Align an additional $16 million in lieu of the development and distribution agreement.

This settlement between Align and Straumann brought an end to outstanding patent disputes  in the U.S., the U.K. and Brazil, including those involving ClearCorrect, a subsidiary of Straumann. As part of this settlement, Align and Straumann signed a non-binding letter of intent for a 5-year global development and distribution agreement whereby Straumann would distribute 5,000 iTero Element scanners which would be fully integrated into the Straumann/Dental Wings CARES®/DWOS® workflow. Additionally, the parties considered exploring the possibility of offering existing iTero users access to Straumann’s prosthetic and surgical planning workflows.

/EIN News/ -- About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, and iTero® intraoral scanners and services. Align’s products help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. Visit for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit For additional information about iTero digital scanning system, please visit

Align Technology       Zeno Group:
Madelyn Homick       Sarah Johnson
(408) 470-1180       (828) 551-4201


Distribution channels: Healthcare & Pharmaceuticals Industry, Law

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.